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Abstract
Overexpression of matrix metalloproteinase 2, MMP-2, is correlated with highgrade gliomas in vivo. The purpose of this study was to investigate whether MMP-2
overexpression in glioma cell lines leads to increased invasion of glioma cells in vitro.
The entire MMP-2 gene was isolated from U87, a glioma cell line known to have high
expression of wild-type MMP-2. This :tvIMP-2 gene was inserted in a sense and antisense
orientation into pCR3 .1 vectors with a CMV promoter to ensure high levels of
expression. Glioma cell lines were transfected with the sense and antisense comtructs, as
well as the pCR3.l vector alone to serve as a control. Zymography and Western blot
analysis of conditioned media taken from glioma cell lines U251, T98, and LNZ-308
transfected with sense MMP-2 revealed an overproduction ofMMP-2 relative to controls.
The invasiveness of these transfected cell lines was evaluated using an in vitro invasion
assay. These assays revealed significantly more invasion by cells that were
overproducing MMP-2 relative to cells containing either vector alone (control) or vector
containing the antisense construct. These results support the hypothesis that glioma cell
lines overexpressing MMP2 are more invasive in vitro.
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Introduction
Matrix metalloproteinase 2 (MMP-2) has recently been associated with glioma
invasion. It is known to cleave components of the extracellular matrix including collagen
type I, N, and V, as well as, elastin, fibronectin, and laminin (Uhm et al., 1997). MMP-2
expression in several glioma cell lines has been manipulated through the use of sense and
antisense human MMP-2 cDNA. The aim of this thesis research is to study the effects of
changes in MMP-2 expression level on the invasiveness of gliomas.
Gliomas are brain tumors that begin in the glial cells, or supportive cells of the
brain. Despite modem advances in surgical techniques, neuroimaging, chemotherapeutic
agents, and radiation strategies, glial tumors are basically incurable. Even withan
aggressive use of these techniques, the average survival time for patients with these
tumors is less than two years. The tumor cells invade the normal brain tissue in a way
that is not well visualized by current imaging techniques and in areas that are difficult to
remove. In addition, evidence suggests that malignant gliomas are prone to genetic
instability, thereby favoring tumor expression. Finally, these tumors are resistant to
ionizing radiation (IR) and therefore, even after the removal of the tumor bulk the
remaining tumor cells resume growth (Broaddus et al., 1999).
The most common and malignant of brain tumor is gliomablastoma multiforme.
These tumors are characterized by the occurrence of necrosis, vascular proliferation, and
aggressive invasion into adjacent normal brain tissue as seen in Figure 1. The diffusely
infiltrative nature of glioblastoma multiforme is one of the chief obstacles to its
successful surgical control (Kondraganti et al., 2000).
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Figure 1:The large white area in the lower right represents a parietal glioblastoma
multiforme shown by magnetic resonance imaging (MRI) (www.med.hanard.edu)
The extracellular matrix, composed of structural components such as collagens,
proteoglycans, and glycoproteins, is the scaffolding in which both normal and tumor cells
reside. Excessive breakdown of the extracellular matrix is associated with cancer, as well
as arthritis, ulceration, emphysema, and cardiovascular disease (Nagase and Woessner,
1999). Though many enzymes have the ability to degrade components of the
extracellular matrix, including cystine and serine proteases, the matrix metalloproteinase
family is known to be particularly significant in matrix degradation. These enzymes are
believed to play a key role in the invasiveness and metastatic ability of a variety of
malignant tumors (Kondraganti et al., 2000).
The matrix metalloproteinase (MMP) family is currently comprised of twentyfour members. These enzymes have overlapping substrate specificities and collectively
have the ability to degrade almost all of the components of the extracellular matrix.
MMPs exist in both invertebrates and vertebrate species. In vertebrates, they are
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expressed primarily in connective tissue cells and in cells that have originated in the bone
marrow (Morgunova et al., 1999).
All MMPs require the binding of two zinc atoms, hence the metallo- prefix. This
binding is essential for proteolytic activity (Lovejoy ct al., 1994). The binding occurs in
the catalytic core domain, which contains the active protein-degrading ability of the
protcinasc. They all contain a signal peptide for synthesis on the rough endoplasmic
reticulum. All MMPs also possess the conserved sequence PRCGXPD in the propeptidc
domain so that the cystinc can function as an activation switch mechanism (Vallee and
Auld, 1990). Removal of the propeptide domain requires cleavage between the first and
second helices within the propcptide bait region, as shown in Figure 2 (Morgunova et al.,
1999). All MMPs, except MMP-7, have a C-terminal domain that has homology to a
scrum protein called hcmopexin. The hemopexin domain is believed to mediate
additional protein-protein interactions with substrates and with naturally occurring
inhibitors (Ward ct al., 1994).
1st activation cleavage site in bait region
2nd activation cleavage site

D

•..

Signal Peptide

D

Fibronectin-likc Domain

Propeptidc Domain

~

Hinge Region

Catalytic Domain

[ ] Hemopexin-like Domain

Figure 2: Detailed protein domains structure and Activation of Pro-MMP-2
of matrix metalloprotcinasc-2. Activation of72kDa pro-MMP-2 occurs by the cleavage
of the amino terminal propeptide in the bait region, resulting in a 64kDa conversion
intermediate. A second cleavage by autoactivation results in the 62kDa active MMP-2.
(Nguyen, 2000).
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MMPs are classified according to the additional protein domains that contribute to
their characteristics (Nagase and Woessner, 1999). The roles of additional functional
domains include modulating protein interactions important in substrate recognition,
providing transmembrane localization, or providing an alternative cleavage site for MMP
activation (Murphy et al., 1994). The members of the MMP family have been divided
into six subgroups: interstitial collagenases, gelatinases, stromelysins, metalloelastases,
secreted RXKR-containing MMPs, and membrane type MMPS (MT-MMPs) (Theret et
al., 1998).
MMPs are highly regulated. Expression, secretion, and activity levels are under
tight control. MMPs are expressed at very low levels, if at all. At times of active tissue
remodeling, expression is rapidly induced (Nagase· and Woessner, 1999). The activity of
MMPs is controlled extracellularly through the cleavage of the pro-domain from the
inactive MMP ·to create the catalytically active MMP. Activity is further regulated by
interactions with their natural inhibitors, the tissue specific inhibitors of matrix
metalloproteinases (TIMPs). The four members of this family are collectively capable of
binding and inhibiting the activity of all members of the MMP family (Gomez et al.,
1997).
Matrix metalloproteinase-2 is a 72kDa type IV collagenase, also called gelatinase
A. The MMP-2 gene, located at locus q21 on human chromosome 16, is 27 kilobases
consisting of 13 exons and 12 introns (Huhtala et al., 1990). The introns are removed
during processing to create a 6.9 kb mRNA molecule, from which a 1.98 kb structural
fragment is translated into a 660 amino acid protein. The signal peptide directs pre-
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proMMP-2 to the rough ER, which directs it into the secretoiy pathway. The signal
peptide is cleaved and proMMP-2 is secreted from cells as a zymogen (progelatinase A)
(Strongin et al., 1993). MMP-2 is primarily expressed in mesenchymal cells, mainly
fibroblasts, during development and tissue regeneration It was originally isolated from a
malignant mouse tumor and was found to be highly expressed in stromal cells
surrounding the invading front of a metastasizing tumor (Morgunova et al., 1999).
The activity ofMMP-2 in the extracellular environment is cortrolled by various
activators and the endogenous tissue inhibitors of matrix metalloproteinases (TIMPs).
Activation of72kDa MMP-2 occurs by the cleavage of the amino terminal propeptide,
resulting in a 64kDa conversion intermediate with an amino terminus at N-Leu3 3 . This
intermediate is converted to a N-Tyr81 62kDa active form, as shown in Figure 2.
Crosslinking and activation experiments demonstrate that membrane-associated TIMP-2
interacts with the carboxyl-end domain of MMP2 and is an essential part of the cell
surface activation complex (Strongin et al., 1995). Recent data suggests that TIMP-2
may mediate the cell surface activation ofMMP-2 by binding to an MTl-MMPcontaining complex on the cell surface. The two may act together as a receptor for proMMP-2 and lead to the cleavage of this zymogen (Theret et al., 1998).
Matrix metalloproteinase-2 (MMP-2) is transcriptionally regulated by p53, a
tumor suppressor gene and transcription factor. p53 plays an important role in
determining whether a cell will undergo differentiation, senescence, or apoptosis. It stops
cell cycle progression at both the G1 checkpoint before replication of damaged genetic
material and the G2/M transition. Loss of cell cycle control, due to a loss of functional
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p53, is believed to contribute to tumor development. Furthermore, p53 is able to trigger
DNA damage-induced apoptosis, or programmed cell death. Apoptosis is necessary for
the development of the CNS as well as in tumor prevention and treatment (Fulci and
VanMeir, 1999). Therefore, it appears that p53 plays a vital role in inhibiting
tumorigenesis in many types of cancer.
A p53 binding site in the promoter of the human MMP-2 gene has been identified.
A number of studies strongly suggest that the MMP-2 gene is a p53 target gene and that
its expression is subject to p53 regulation. These studies have shown that activation of
the promoter activity is p53-binding dependent in p53 positive cells but not in p53
negative cells. Only wild-type p53, not p53 mutants commonly found in human cancers,
induces MMP-2 expression. Expression of endogenous MMP-2 is also under control of
p53 (Bian and Sun, 1997).
A feature commonly associated with tumor invasion and angiogenesis is the
degradation of the extracellular matrix, basement membrane, basal laminae, and
interstitial stroma. Basement membranes contain type IV collagen as a major component
as well as laminin, fibronectin, heparan sulfate proteoglycan and entactin (Shina et al.,
1991). Neoplastic cells that invade surrounding tissues and go on to metastasize through
the bloodstream must penetrate the basement membranes of the blood vessels in order to
enter and to leave the vascular compartment, as shown in Figure 3. Therefore, the ability
of neoplastic cells to degrade basement membranes is one important determinant of
metastatic potential. This realization led to the discovery of gelatinase A or, now more
commonly known as MMP-2, which degrades type IV collagen as well as other
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components of the extracellular matrix. MMP-2 is involved in the extracellular matrix
remodeling in a wide range of non- neoplastic processes, such as regulation of cell
proliferation and differentiation (Liotta et al., 1979).

llti;\l'Hlt\Hl

Membnuw
1Jissu~utirm

nlfKMl Vmi{'Utur

fn,asiricn

L}mptnttk
fn\·<.tSlttO

Figure 3: Destruction of the basement membrane and invasion of neoplastic cells
(Liotta, 1983).

MMP-2 expression has been linked to tumor invasion. Unlike other MMPs, the
activation of MMP-2 takes place on the cell surface, which confers a pivotal role in
migration and growth of tumor cells (Theret et al., 1998). Angiogenesis and
corresponding tumor growth have been shown to be reduced in MMP-2 knockout mice
(Itoh et al., 1998). Other studies have shown the importance of activation ofpro-MMP-2
for the invasion and metastasis of many types of human cancers such as gliomas, breast
carcinomas, thyroid papillary carcinomas, ovarian carcinomas, gastric adenocarcinomas,
and oral squamous cell carcinomas (Okada, 2000). Previous studies have investigated
relative amounts ofMMP-2 production in the normal brain in comparison to amounts in
low-grade gliomas and amounts in more highly invasive malignant astrocytomas. Much
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higher MMP-2 levels were localized to tumor and vascular endothelial cells in malignant
astrocytomas in comparison to low-grade gliomas and normal brains (Lampert et al.,
1998).

Evidence suggests a correlation with MMP-2 expression and glioma invasiveness.
This study further investigates this correlation and looks for a more direct link between
an increase in MMP-2 expression and an increase in invasion. In order to do this, it was
necessary to create and characterize a mammalian expression system, which contained
full length MMP-2 cDNA in the sense and antisense orientation. A sense construct is
used to manipulate the cells to overproduce a specific protein, in this case MMP-2.
Antisense constructs are designed to bind to a specific sequence of nucleotides in its
mRNA target to inhibit production of the protein encoded by the target mRNA. In this
case, antisense MMP-2 binds to the MMP-2 mRNA produced by the glioma cells, thus
blocking MMP-2 synthesis as shown in Figure 4. By acting at this earlier stage in the
disease-causing process to prevent the production of a disease-causing protein, antisense
drugs have the potential to provide greater trerapeutic benefit than traditional drugs
which do not act until the disease-causing protein has already been produced.
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Materials and l\1ethods
Maxi Prep to Extract Plasmid Constructs from Transformed E.coli cells
The DNA used in this experiment was extracted from glycerol stocks of MMP-2 clones
received from the William Broaddus and Helen Fillmore laboratories at Virginia
Commonwealth University- Medical College of Virginia. The QIAprep Spin (QIAGEN)
endo-free maxiprep kit was used to extract the plasmid constructs from the TOPI OF'
colonies. The endo- free kit was used because lysis of bacterial cells release endotoxins
which reduce transfection efficiency. Luria broth (LB) (3ml) cottaining kanamycin was
inculated from the glycerol stock. Each culture (lml) was grown overnight in lOOml of
LB. Extraction was performed according to the manufacturer's instructions. The process
of extracting the plasmid involves alkaline lysis of bacterial cells followed by adsorption
of only DNA onto a silica-gel membrane. Following washes, centrifugation, and eluation
steps, one obtains high recovery of pure plasmid DNA. The DNA was eluted in 500µ1 of
TE.

Cell Culture
The cell lines used in this experiment T98, U251, LNZ-308, U373, and RT2, were
obtained from the Medical College of Virginia at Virginia Commonwealth University.
The cell lines were maintained in 7Sent flasks in Dulbeco' s Modified Eagle Medium or
DMEM (Gibco/BRLl 1965-092) with high glucose, pyridoxine HCL, and LGlutamine.
The media was supplemented with 10% fetal bovine serum (FBS) (Gibco/BRL 16000044) that was previously heat inactivated, 1% nonessential amino acids (Gibco/BRL
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11140-050), 0.1 % gentamicin sulfate (BioWhittaker 17518Z) and 1% penicillinstreptomycin(Gibco/BRL 15140-122).
To pass the cells under sterile conditions, the old media was removed the cells and the
cells were washed with 6.0ml phosphate buffered saline. 1OX Trypsin-EDTA (Sigma
T4171) diluted 1 part in 4 in serum- free media was added to the cells and they were
incubated at 37°C for 3-5 minutes or until a majority of the cells were floating. The
contents of the flask were then transferred to a sterile 50ml centrifuge tube and
centrifuged at 1300rpm for ten minutes at room temperature. The supernatant was
removed and the pellet was resuspended in 5-25ml ofDMEM...;fBS depending on pellet
size. In order to count the cells, 1: 10 and 1: 1000 dilutions of the cell suspensions were
made. 1Oµl of each diluted salll'le was added to each end of a hemacytometer. The cells
were counted in four comers of the grid and an average was taken. The average number
of cells was multiplied by 10,000 and then by the dilution factor to obtain the total
number of cells per ml. The desired number of cells was then added to a flask containing
DMEM-FBS.
U251, U373, RT2 and LNZ cell lines were stably transfected with the MMP-2 gene in the
sense and antisense orientation through previous work conducted at the Medical College
of Virginia. The cells were also transfected with the control pCR3.1 vector. These cells
were maintained in a specific concentration of Geneticin (the brand name of G418 from
Gibco/BRL 10131-035) determined by a kill curve. This procedure selects only stably
transfected cells. All of the cells are kept in an incubator at 5% C02, 95% humidity and
37°C.
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Creating a G418 Concentration Kill Curve
Prior to transfection it was necessary to determine the concentration of G418 to use for
tranfectant selection. The cone entration of G418 must be just high enough to kill all cells
that did not pick up the pCR3.l vector during transfection. A G418 kill curve was
generated with increasing concentration of Geneticin for the cell line T98. G418 is an
analog of the neomycin aminoglycoside that interferes with the function of 80S
ribosomes and blocks protein synthesis in eukaiyotic cells. The neomycin resistance
gene encodes a protein that transfers a phospho-, acetyl, or nucleotidyl- group onto the
aminoglycoside, thus inactivating it. Each cell line was seeded at 1X105 cells/well in a
24 well plate. After reaching 80-100% confluence, 0 .25mg/ml to 2mg/ml of G418 was
added. The cells were monitored over four days. The lowest concentration of G418 that
left the majority of cells dead and floating was the concentration chosen to use for
selection of transfected cells.

Transfection of Cell Lines with Sense and Antisense MMP-2 and Control Vector
The cell lines were transfected using Lipofectamine 2000 (Gibco/BRL 11668-019).
Lipofectamine 2000 is lipo.some-mediated means of transferring DNA into mammalian
cells. With cationic lipid reagents, the negatively charged DNA binds spontaneously to
the positively charged liposomes, forming DNA-cationic lipid reagent complexes. The
liposome complexes fuse with the plasma membrane and the captured DNA is then
delivered into the cytoplasm of the cultured cells. Cells were plated in 24-well plates the
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day before transfection at a concentration of 4Xl 05 cells/ml. Twenty-four hours later,
l.Oµg of DNA per well was diluted in 50µ1 ofDMEM-FBS lacking antibiotics. 2.5µ1 of
Lipofectamine 2000 was diluted in 50µ1 ofDMEM-FBS also lacking antibiotics.
Antibiotics were excluded from the media because the cationic lipid reagents increase the
cells' permeability and allow delivery of antibiotics into the cells. This decreases the
health of the cells, thus lowering transfection efficiency. The diluted DNA and diluted
lipofectamine were combined in microfuge tubes and incubated for twenty minutes at
room temperature. The complexes were then added to the cells, which were then
incubated for twenty-four hours. Transfection control cells were given DNA or
lipofectamine. Twenty-four hours after transfection the cell lines were passed to 6-well
plates. Twenty-four hours after the cells were passed, G418 was added to the cells at a
concentration of 1.0 mg/ml (determined by a kill curve, to select for the transfected cells).
The cells were observed daily for the formation of colonies. Cloning rings and trypsinEDTA (Sigma) were used to isolate and pass each colony to individual wells.

Determining Protein Concentration Using the Bradford Assay
Bradford assays were conducted on all protein samples prior to zymography or W estem
blot analysis to stanlardize protein concentration. BioRad Dye Reagent was diluted 1:5
in superwater and filtered using Whatman No. I filter paper. 100µ1 of sample was added
to 5ml of dye and allowed to sit for 5 minutes. Absorbance was read at 595nm on a
Spectronic 21. Protein concentration was determined by the standard curve equation
Slope =0.01 IA/µg.
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Determining MMP-2 Activity Via Zymography

The transfected cell lines were analyzed for MMP-2 activity induction by zymographic
substrate gels. Zymogram gels (NOVEX EC6I 75) are 10% Tris-Glycine gels
copolymerized with O. I% gelatin such that the activity of the enzyme can be assessed
within the gel. The transfected cell lines were incubated with serum free media for 48
hours then the media was removed. Protein concentratims of each sample were
standardized by a Bradford assay. I5µ1 of the samples were mixed with I5µ1 TrisGlycine SDS Sample Buffer (NOVEX LC2676). The mixtures were allowed to stand for
10 minutes at room temperature. The gels were run at I20 volts for 90 minutes with IX
Tris-Glycine SDS Running Buffer (NOVEX LC2675). The gel was then incubated in IX
Renaturing Buffer (NOVEX LC2670) for thirty minutes at room temperature and then
equilibrated in IX Developing Buffer (NOVEX LC267 I) at room temperature.
Following staining for thirty minutes with O. I% Coomassie Blue, gels were destained
with I 0% isopropanol and I 0% glacial acetic acid approximately one hour or until clear
bands could be seen. The gel was then visualized on a light box.

Determining MMP-2 Expression Via Western Blot Analysis

Western blots were used to analyze cell lines for the production of pro-MMP-2. The
transfected cell lines were incubated with serum free media for 48 hours and the media
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was removed. Protein concentrations of all samples were standardized by a Bradford
assay. 20µ1 of each sample was added to 4X Sample Buffer (NuPAGE NP0007). 2.5µ1
of Reducing reagent (NuPAGE NP0004) was added to each sample and the samples were
incubated at 70°C for ten minutes. The samples were loaded into a Bis- Tris-HCl
buffered polyacrylamide gel (NuPAGE NP0321) containing lX Running Buffer
(NuP AGE). 200µ1 of antioxidant was added to the buffer filling the inner buffer
chamber. The gel was run at 200 volts for 35 minutes. Transfer buffer was prepared by
diluting Tris Glycine Transfer Buffer (NOVEX, NP0005) with deionized water and 10%
methanol. The transfer buffer was kept ice cold. Blotting pads were soaked in transfer
buffer. A nitrocellulose membrane was soaked in deionized water then transfer buffer.
Two pieces of filter paper were soaked in transfer buffer immediately prior to use. The
gel membrane apparatus was assembled with two blotting pads in the cathode core,
followed by a piece of filter paper, followed by the gel and nitrocellulose membrane, then
two more blotting pads. The chamber was filled with ice-cold transfer buffer and the
transfer was run at 30 volts for 1 hour. The membrane was removed from the transfer
apparatus and put in a hybridization bottle with the protein side facing the interior. It was
then blocked in blocking solution (consisting of 3 .0% nonfat dry milk and TBS) for 2
hours at room temperature. It was then washed in lX TBS (consisting of l.54M NaCl
and O.lM Trizma) for five minutes. A 1:2000 dilution of rabbit MMP-2 primary
antibody (Chemicon AB809) in TBST (consisting of TBS, 0.1 % Tween, and 0.2% nonfat
dry milk) was then added to the blot for 2 hours at room temperature. It was then washed
three times for ten minutes each in TBST. A 1:5000 dilution of horseradish perxodase
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conjugated goat anti-rabbit secondary antibody (Rockland 611-1302) in TBST was added
to the blot for 1 hour at room temperature. The blot was then washed 4 times with 1Oml
TBST for five minutes each. The membrane was incubated with 7 ml ECL detection
reagents for one minute 1:1 v:v;0.125ml/cnt membrane. The reagent was drained from
the membrane and it was smoothly wrapped in saran wrap and developed in the dark
room. The Polaroid film was exposed for one minute, developed for 2 minutes without
agitation, soaked in stop bath for 30 seconds with agitation, soaked in fixer for 2 minutes
with intermittent agitation and then washed under running water.

Fluorescent labeling of Cells
Cells were fluorescently labeled by Dil (Molecular Probes, V-22885), a long-chain
dialkylcarbocyanine that uniformly .labels through lateral diffusion into the plasma
membrane. Cells were grown up in 6 well plates to approximately 90% confluence, then
were washed with PBS. Dil was diluted 1:200 in lmL serum free media. 2mL of diluted
Dil was added to each well of cells. The cells were incubated with Dil overnight. The
media was then removed and the cells were washed with PBS three times. The cells were
then trypsinized and counted.

Invasion Assay
An in vitro invasion assay was conducted to determine whether the cell lines that are

overproducing MMP-2 are in fact more invasive. Matrigel basement membrane matrix
(Becton Dickinson) extracted from Englebreth-Holm-Swarm (EHS) mouse tumor can be
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used as a reconstituted basement membrane in vitro that provides a biologically active
extracellular matrix. The matrix has been shown to contain collegen IV, laminin,
entactin, heparan sulfate, and proteoglycan. The 204µ1 matrigel matrix was diluted in
1. 796ml serum free DMEM. 50µ1 was added to each transwell permeable growth
support (COSTAR 3422). The plate was then be incubated for 40 minutes at 37°C to
allow binding. The media was then removed from the inserts and they were washed with
DMEM. Then 50µ1 of a concentration of 1X105 cells/ml was added to each insert.
DMEM was added to the lower compartment to serve as a chemoattractant. Invasive
cells attach to and invade the matrix, pass through the membrane pores, and emerge on
the underside of the membrane, while non- invasive cells do not migrate through the
occluded pores.

Plate Reading

Invasion assay plates were read every 24 hours for five days. Fluorescence was read by
BMG Labtechnologies FLUOstar Galaxy. The excitation filter was set at 544nm and the
emission filter was set to 590nm.
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Results:
At the Broaddus/Fillmore Laboratories at Virginia Commonwealth UniversityMedical College of Virginia, MMP-2 was cloned and ligated into the bi-directional
pCR3. l vector as seen in Figure 5. Competent E.coli cells were transformed by heat
shock. The SV40 early promoter and the neomycin/kanamycin resistance gene allowed
for selection of transformed E.coli colonies. Restriction enzyme analysis was used to
determine the presence and orientation ofMMP-2 in pCR3.l vector. Automated
Fluorescent Dideoxy Sequencing was used to verify orientation and sequence of the
cloned genes. One clone containing MMP-2 in the sense orientation, antisense
orientation, and the control vector were frozen in glycerol for further use.

CMV promoter

Seal
Ampicillin
Seal
SV40 promoter and origin

MMP2-pCR3.1

7043 bp

MMP2

N eomycin/Kanamycin

pUC origin

Figure 5: MMP-2 cDNA was inserted in the sense and antiscnse orientation into a
pCR3. l vector with a CMV promoter for high-level expression. Glioma cell lines were
transfccted with sense/control/antisense DNA constructs.
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Maxi Prep
The glycerol stocks were obtained from the Broaddus/Fillmore laboratories to
extract the plasmid DNA to be used in transfection. QIAprep Spin endo-free maxiprep
kit was used to extract the plasmid constructs from the TOPlOF' E.coli cells. The DNA
concentrations were determined by UV spectrophotometry as 345ng/ µl control DNA,
271.5ng/µl sense DNA, and 586ng/µl antisense DNA. A 1% agarose gel was run at 90
volts for 30 minutes to ensure the integrity of the DNA. Figure 6 shows that the plasmid
DNA is intact.

Antisense

Control

Figure 6: 1% agarose gel to detem1ine plasmid DNA integrity.

Kill Curve

Prior to transfection it was necessary to determine the concentration of G418 to
use for tranfectant selection. The SV40 early promoter and the neomycin/kanamycin
resistance gene in the pCR3. l vector allowed for selection of stably transfected cell lines.
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A G4 l 8 kill curve was generated with increasing concentrations of Geneticin for the cell
line T98 as shown in Table 1. The cells were observed over 4 days.

Concentration of G418 J_m_gfm!l Cell Culture Observations

0.00
0.25
0.50
0.75
1.00
1.25
1.50
1.75
2.00

All cells alive and healthy
All cells alive and healtl!t_
Some cells dead and floating, some healthy_ cells
Most cells dead and floating; few adherent cells no
longer have processes and appear unhealthy
All cells are dead and floating_
All cells are dead and floatin__g_
All cells are dead and floatin__g_
All cells are dead and floating
All cells are dead and

floati~

Table 1: Observations ofT98 cells after 4 days of treatments with designated
concentrations of G4 l 8.
The ideal concentration of G418 to be used for transfection selection is the concentration
that is just high enough to kill all cells that did not pick up the pCR3.l vector during
transfection. The lowest concentration of G418 that killed all of the T98 cells was
l .OOmg/ml. This concentration was used to select for transfected T98 cells.

Transfection
The next step of this study was to establish several stably transfected glioma cell
lines. Each glioma cell line was transfected with MMP-2 in the sense orientation, MMP2 in the antisense orientation, and pCR3.l vector to serve as a control by cationic lipid
reagent-mediated transfection Following transfection, the concentration of G4 l 8
determined by the kill curve was added to the cells for selection. Cells that survived
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selection were allowed to grow up into large macroscopically visible colonies. Several
colonies resulted from each transfection and were differentiated by number as shown in
Table 2. These colonies were then isolated by the use of cloning rings as shown if Figure
7. Each of these colonies resulting from transfection was grown up until there were
enough cells present to collect conditioned media from the cells to be analyzed for MMP2 production.

Colonies isolated by
cloning rings

Figure 7: Cloning rings dipped in celloseal were placed over the colonies resulting from
transfection. Each transfection resulted in several colonies. The colonies were collected
and expanded to separate plates to allow each colony to grow.

T98
LNZ-308
U251
Sense Anti sense Contra Sense Antisense Control Sense Anti sense Control
1
1
1
1
2
1
1
1
5
2
2
5
6
3

3

Table 2: Colonies resulting from transfection analyzed by zymography and Western blot
analysis
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Zymography and Western Blot Analysis

Once the transfcctcd cells had grown to confluence, it was essential to test the
MMP-2 status to be sure that the transfection worked properly and to screen the cells for
use in further use in invasion testing. The MMP-2 production of the transfccted cell lines
was characterized through the use of Western blots to analyze MMP-2 induction and
zymography to analyze MMP-2 activity. It was hypothesized that little to no MMP-2
induction or activity would be present from the cells transfectcd with the control or
antiscnse MMP-2 and increased expression and activity of MMP-2 would be present
from the cells transfectcd with the sense MMP-2.
For zymography and Western blot analysis, conditioned media was collected from
the cells to analyze MMP-2 secreted from the cells. The transfected cell lines were
incubated with serum free media for 48 hours and the conditioned media was removed.
Protein concentrations of all conditioned media samples were standardized by a Bradford
assay. Assays were run with 25µg of protein as soon as possible after collection from the
cells.

Figure 8: Zymograms of U251 Conditioned Media Samples. Conditioned media samples
were assayed 24 hours after collection from U251 cells. Each gel represents data from
two experiments. In each gel, lane 1 control clone #1, lane 2 sense clone #5, lane 3 antiscnse clone #1, and lane 4 anti-sense clone #6. All lanes were loaded with 25µg protein
determined by a Bradford assay.
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' 1.

Figure 9: Western Blot Analysis ofU251 Conditioned Media Samples. Conditioned
media samples were assayed 2 hours after collection from cells. Lane 1 contains a
molecular weight marker, lane 2 control clone #1, lane 3 sense clone #5, lane 4 anti-sense
clone #1, and lane 5 anti-sense clone #6. All lanes were loaded with 25µg protein
determined by a Bradford assay.

Zymograms and Western blots were conducted in triplicate on the U251 cells to
analyze MMP-2 activity and expression respectively. Representative data from these
experiments is shown in Figures 8 and 9. Both zymogram gels in Figure 8 show that the
U251 sense 5 cells appear to be overproducing gelatin degrading enzymes such as MMP2 (lane 2). The control in lane 1 and the antisense cells in lanes 3 and 4 seem to be
exhibiting equal expression. Analysis by zymography is necessary to show the gelatinase
activity of the cells, however, this activity not necessarily due solely to MMP-2. The
activity shown from the series of bands on the zymograms is a result of all gelatindegrading enzymes present in the cells. However, the additional upper band seen if
Figure 8 from only the sense cells is due to the presence of transfccted sense MMP-2.
In Western blot analysis of the same samples shown in Figure 9, a clear band
indicating MMP-2 expression can be seen from the U251 sense sample 5 (lane 3).
According to molecular weight markers, this band is approximately 72 kDa, the size of
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pro-MMP-2. No bands were in the U25 l control and sense samples. Similar results were
seen from all of the characterization experiments conducted on the U251 cells.

1

2

3

4

5

6

Figure I 0: Zymogram of T98 Conditioned Media Samples. Conditioned media samples
were assayed 24 hours after collection from cells. Lane I contains the T98 sense clone
#1, lane 2 sense clone #2, lane 3 sense clone #3, lane 4 control clone #1, lane 5 anti-sense
clone #1, lane 6 anti-sense clone #2. All lanes were loaded with 25µg protein determined
by a Bradford assay.

Figure 11: Western blot analysis ofT98 Conditioned Media Samples. Conditioned media
samples were assayed 1 hour after collection from cells. Lane 1 contains the positive
control MMP-2 protein, lane 2 the molecular weight markers, lane 3 contains T98 sense
clone #1, lane 4 contains sense clone #3, lane 5 contains sense clone #2, lane 6 contains
T98 control clone # 1, lane 7 contains anti-sense clone # 1, lane 8 contains anti-sense clone
#2, lane 9 contains anti-sense clone #3. All lanes were loaded with 25µg protein
determined by a Bradford assay.

Zymograms and Western blots were conducted in triplicate on the T98 cells to
analyze MMP-2 activity and expression. In the zymogram shown in Figure I 0 from the
T98 transfccted cells, gelatin degradation was present in each of the samples, however, a

25

double band was seen from the sense# I, sense #2, and sense #3 cells in lanes I, 2, and 3.
The lower band that is present from all of the cells may or may not be due to MMP-2
alone, however the upper band seen from the sense cells is an increase in gelatinase
activity due to transfcction with sense MMP-2.

In the Western blot analysis shown in Figure 11, clear 72kDa bands representing
the presence of MMP2 can be seen in all of the sense cells (lanes 3-5). The strongest
band can be seen from the sense clone #2 in lane 5. A band is also seen from the
antisense clone #3 in lane 9. These cells were discarded because T98 cells transfccted
with antisense MMP-2 should not be overproducing MMP-2. Repeatable results were
seen from the Zymograms and Western blots as these tests were conducted in triplicate.

Figure 12: Zymogram of LNZ-308 Conditioned Media Samples. Conditioned media
samples were assayed 1 hour after collection from cells. Lane I contains LNZ-308
control clone #1, lane 2 antisense clone #2, lane 3 antisense clone #5, and lane 4 sense
clone #1. All lanes were loaded with 25µg protein determined by a Bradford assay.
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1

2

3
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Figure 13: Western Blot of LNZ-308 Conditioned Media Samples. Conditioned media
samples were assayed 24 hours after collection from cells. Lane 1 contains LNZ-308
control clone #1, lane 2 antisense clone #2, lane 3 antisensc clone #5, and lane 4 sense
clone #1. All lanes were loaded with 25µg protein determined by a Bradford assay.

Zymograms and Western blots, Figures 12 and 13, were conducted in triplicate on
the LNZ-308 cells to analyze MMP-2 activity and expression respectively. In the LNZ308 cells, an increase activity can be seen from the sense cells in lane 4 of the zymogram
in Figure 12. Since no gclatinasc activity is seen from the control and the antiscnse cells,
the activity seen from the sense cells is due to transfection with sense MMP-2. A clear
band corresponding to 72kDa MMP-2 is present in lane 4 of the Western blot in Figure
13. No MMP-2 production is apparent from the control or antisensc cells in Figure 13.

Invasion assay

Subsequent to characterizing MMP-2 activity of the U251 cells, an in vitro
invasion assay was conducted to determine if the cells that exhibit increased expression
of MMP-2 arc more invasive in vitro than the control and antisense transfccted cell lines.
Florcscently labeled cells were added to Matrigel coated inserts in quadruplicate for each
cell type. Due to previous studies linking MMP-2 to tumor invasiveness, it was predicted
that the increase of production and activity of MMP-2 produced by the glioma cells
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transfected with sense MMP-2 would lead to increased invasion by these cells. It was
also predicted that the cells transfccted with the antisense MMP-2 constructs would block
MMP-2 induction and show a decrease in invasion.
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Figure 14: U251 stably transfccted with control vector, antisense MMP-2 and sense
MMP-2. The florescence of the cells that had invaded the Matrigel coated transewell
inserts and ended up in the bottom of the wells was measured at a fluorescence emission
of 590nm after 72 hours. The total fluorescence for each of the four wells was averaged
for each cell type. T-tests were run to determine statistical significance.
In the invasion assay in Figure 14, the amount of fluorescence measured on the
bottom of each well is indicative of the degree of invasion of each cell type. A
significant difference in invasion can be seen in comparing the fluorescence of the sense
cells to the control cells, and in comparing the sense cells to the antisense cells. No
significant difference is seen in comparing the amount of fluorescence between the
control and antisense cells. These preliminary results from the in vitro invasion assay
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show significantly more invasion from the sense cells that are overproducing MMP-2
than the control and antisense cells.

Discussion
Cancer is a disease whose hallmark is uncontrolled growth and metastasis. It is
based on a loss of normal growth control that produces a growing tissue mass known as a
tumor or neoplasm. Malignant tumors are capable of spreading by invasion and
metastasis, which involves invasion of surrounding tissues and vessels, transport via the
circulatory system, and reinvasion and growth at a distant sight.
Gliomas are brain tumors containing cells that are highly invasive. Degradation
of the extracellular matrix is necessary for this invasion to occur. Considerable evidence
has accumulated to directly implicate members of the matrix metalloproteinase family in
this process. MMP-2 protein expression has been directly linked to glioma tumor grade,
where an increase MMP-2 mRNA expression is seen in themore invasive high-grade
gliomas (Lampert et al., 1998). This correlative study implicating MMP-2 with invasion
led to further investigation of this topic. Kodera and colleagues have found an increase in
pro-MMP-2 in rat brains implanted with rat glioma cells in comparison to normal rat
brains (Kodera et al., 2000). Noda and his colleagues tested a matrix-metalloproteinase
inhibitor SI-27 on several human glioma cell lines, including U251 and U373. SI-27 was
shown to suppress MMP-2 and MMP-9 expression and to reduce the number of invading
cells migrating through invasion assay inserts (Noda et al., 2000).
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These recent studies clearly demonstrate a correlation between MMP-2
expression and glioma invasion. However, there needs to be a direct link showing that
modulating MMP-2 levels results in changes in glioma invasion. Therefore, the purpose
of this study was to further investigate the correlation between MMP-2 expression and
tumor invasion and to demonstrate that MMP-2 overexpression is the major cause of
glioma invasion.
The first step of this research was to transfect several different human glioma cell
lines with MMP-2 cDNA sense and antisense constructs. The plasmid DNA used in this
experiment was produced from glycerol stocks of MMP-2 clones received from the W.
Broaddus and H. Fillmore Laboratories at Virginia Commonwealth University Medical
College of Virginia. There they conducted zymography and Western blot analysis of the
non-transfected human cell lines U87, T98, U251, U373, and rat RT2, to determine
endogenous MMP-2 expression. The U87 cell line was found to have high endogenous
expression in comparison to the other glioma cell lines. Therefore, total RNA was
extracted from this cell line to clone the entire MMP-2 gene by RT-PCR. This clone was
inserted in a sense and antisense orientation into a pCR3 .1 vector with a CMV promoter
for high- level expression. The constructs were sequenced to determine orientation and
sequence of the cloned genes. The sense and antisense constructs, as well as the pCR3.1
construct alone as a control, was used to transfect the glioma cell lines (Nguyen, 2000).
A kill curve was conducted to determine the concentration of 0418 to be used for
transfection selection. The results from table 1 show a concentration of 1.0 mg/ml as an
ideal concentration for selection of transfected cells.
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The transfected cell lines were then characterized using zymography and Western
blot analysis of conditioned media samples. These tests show the expression and activity
of MMP-2 released from the cells. A significant difference in MMP-2 expression was
seen in the zymograms and Western blots resulting from the U251, T98 and LNZ-308
cell lines. The U251 zymogram shows a clear overproduction of gelatin degrading
enzymes from the cells transfected with sense MMP-2. The upper band seen in Figure 8
from the cells transfected with sense MMP-2 must be due to MMP-2 activity since it is
not present in the cells transfected with antisesense or control MMP-2. The cells
transfected with antisense MMP-2 and the cells transfected with control MMP-2 exhibit
equal expression, but in a lesser quantity. than the sense cells. It is interesting that the
increase in MMP-2 activity exhibited on thezymograms appears as an additional upper
band as seen from the cells transfected with sense MMP-2 in Figure 8. Since pro-MMP-2
is a 72kD protein and active MMP-2 is 62kDa, one would have predicted the increase in
MMP-2 activity to appear as a band of lower molecular weight, corresponding to the
62kDa active form ofMMP-2. It is possible that the cells transfected with sense MMP-2
are exhibiting so much proteolytic activity that a column of bands resulted. Since
molecular weight markers do not appear clearly on the zymogram gels after staining with
Coomassie blue, it is difficult to determine the exact molecular weight of the bands
present in the zymogram.
In Western blot analysis of the same samples using an MMP-2 specific antibody,

a clear band of 72kDa, correlating with the known molecular weight of pro-MMP-2, can
be seen from the U251 cells transfected with sense MMP-2, indicating MMP-2
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expression as seen in Figure 9. Little to no MMP-2 expression was seen in the samples
taken from the U251 cells transfected with antisense or control MMP-2 on the Western
blots. From these experiments, it is evident that transfectionwith sense MMP-2 lead to
an overproduction ofMMP-2 in these cells, while transfection with control and antisense
MMP-2 did not lead to an increase in MMP-2. Since there were no differences seen in
either the Western blots or zymograms from the U251 control and antisense, we cannot
determine iftransfection with antisense MMP-2 has blocked the induction of MMP-2.
Results similar to those seen in the U251 cell line were observed in the T98 cell
line. Zymography of the samples taken from the T98 transfected cells showed gelatinase
activity in each of the samples, however, the greatest activity was seen in the all.of the
cells transfected with sense MMP-2 as seen if Figure 10. As in the U251 samples, the
enzyme activity appears as an additional higher molecular weight band that is absent in
the samples from the cells transfected with control and antisense MMP-2. In the Western
blot analysis, Figure 11, a 72kDa band representing the presence ofMMP2 was seen in
each of the samples from the cells transfected with sense MMP-2 indicating an increase
in Ml\1P-2 expression in these cells. Little to no expression of MMP-2 from the antisense
and control cells was evident from Western blot analysis. The T98 antisense clone #3
that exhibited increased MMP-2 expression on the Western blot was not used in further
experiments since increased MMP-2 expression was not expected from these cells. No
difference in MMP-2 expression was seen when comparing the cells transfected with
antisense MMP-2 and the cells transfected with control MMP-2, so just as in the U251
cells, it remains to be seen if the antisense MMP-2 is blocking MMP-2 induction in the
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T98 cells. The results do illustrate that transfection of T98 with sense MMP-2 caused an
overproduction ofMMP-2 in these cells.
Results analogous to those seen in the characterization of U251 and T98
transfected cells can also be seen in the LNZ-308 transfected cells. As shown in Figure
12, gelatinase activity was seen in only the cells transfected with sense MMP-2, not those
transfected with control or antisense MMP-2. In these cells, the degradation appears as a
smear, not the distinct bands observed in the T98 and U251 samples from the cells
transfected with sense MMP-2. The differences in gelatin degradation between these cell
lines would be interesting to explore further.
An overproduction ofMMP-2 was observed in the cells transfected with sense

MMP-2 in the Western blot analysis in Figure 13., No MMP-2 production was apparent
from the cells transfected with control vector or antisense MMP-2. Therefore, the LNZ.
308 cells transfected with sense MMP-2 exhibited an overproduction of MMP-2, while
no detectable differences in MMP-2 expression could be seen in the cells transfected
antisense MMP-2 and control MMP-2 using zymography and Western blot analysis for
characterization.
As a whole, the results from the characterization ofMMP-2 activity by
zymography and MMP-2 expression by Western blot analysis for the cell lines U25 l,
T98, and LNZ-308 supported the hypothesis that transfection with sense MMP-2 would
lead to an overproduction of this enzyme. These transfected cell lines can now be used in
future experiments to relate the affects of this overexpression ofMMP-2 on invasion.
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Two other glioma cell lines transfected at the Broaddus/Fillmore Laboratories,
RT2 and U373, were also characterized through zymography and Western blot analysis.
Results from the RT2, a rat glioma cell line, showed no differences in MMP-2 expression
between the cells transfected with sense, antisense and control MMP-2 in both Western
blots and zymograms. It is possible that these cells lost the MMP-2 DNA during cell
culture. These cells were not tested further. Human U373 cells were also characterized in
a.similar manner. Both of these tests showed greater MMP-2 expression from the cells
transfected with control MMP-2 than those transfected with sense MMP-2. These cells
may have not been transfected properly. Due to the unexpected results from these tests,
caused possibly by loss of the plasmid or unsuccessful transfection, and the number of
cells lines that were already being studied, these cells· were no longer tested.
In future studies involving characterization of MMP-2 expression and activity in
glioma cells, it may be useful to create an assay that could quantify MMP-2 expression
and activity. This would be particularly valuable in determining if the cells containing
the antisense construct are truly blocking MMP-2 induction and to what degree. A
further means of testing the MMP-2 blocking ability of the antisense construct would be
by transiently transfecting the cells that have been previously transfected with sense
MMP-2, with the antisense construct. Our results have shown that the cells transfected
with sense MMP-2 show an increase in MMP-2 expression and activity. If the antisense
construct were working, a decrease in MMP-2 expression and activity would be
predicted. Another useful experiment would be to develop a means of differentiating
pro-MMP-2 from active MMP-2 by a method other than molecular weight. This could be
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done by the use of different antibodies specific for different portions ofpro-MMP-2 and
MMP-2.
After characterizing the MMP-2 status of the transfected cell lines, it was
important to test the invasiveness of these transfected cells to see if the cells transfected
with sense MMP-2 exhibited and increase in invasion in vitro. Rotary and colleagues
examined the in vitro invasion process of epithelial cells using Matrigel, which provides a
reconstituted basement membrane to study cellular invasion through extracellular matrix
components (Rotary et al., 2000). In such invasion assays conducted in the past, it was
necessary to fix and stain the cells before counting them. This was a tedious process with
questions arising about the accuracy and reproducibility of the results. In addition, cells
could not be counted at multiple time intervals. I have developed an assay using
fluorescent-labeled glioma cells. By labeling the cells with DiI, a highly lipophilic
carbocyanine dye, I am able to count invading cells in real time. In addition, I believe
this system provides a more accurate and reproducible assessment of invading cells than
the manual methods.
Using fluorescent-labeled cells, results from the U251 invasion assay show a
statistically significant difference in invasion in comparing the fluorescence ofthe cells
transfected with sense MMP-2 to the cells transfected with control MMP-2, and in
comparing the cells trarnfected with sense MMP-2 to the cells transfected with antisense
MMP-2. No significant difference is seen in comparing the amount of fluorescence
between the control and antisense cells. These preliminary results show significantly
more invasion from the cells transfected with sense MMP-2 that are overproducing
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MMP-2 than the cells transfected with control and antisense MMP-2, in support of my
hypothesis.
I also hypothesized that there would be significantly less invasion from the U251
cells transfected with antisense MMP-2 than the cells transfected with control MMP-2.
This hypothesis was not supported by the results. The fact that we see no difference in
invasion between the control and antisense cells could be due to a number of reasons.
First, it is possible that the antisense MMP-2 is not blocking MMP-2 induction. This
could be examined by a test that quantified MMP-2 induction. It is possible that fulllength antisense MMP-2 RNA is so long that it provides the opportunity for the antisense
RNA to form secondary structure which would not allow it to bind to the MMP-2 mRNA,
thus not blocking MMP-2 induction. It could be corrected by creating an antisense
construct that contained only a portion of the antisense MMP-2 in opposed to the entire
gene. The characterization experiments using Western blot or zymography have not
shown any difference in MMP-2 expression between the control and antisense cells. In
future experiments it would be beneficial use an assay for characterization ofMMP-2
production that could quantify concentrations ofMMP-2, such as an ELISA. By such a
test, we would know if the antisense is truly working and to what degree it is blocking
MMP-2 induction.
An invasion assay, similar to one described for the U251 cells, was conducted by
the Broaddus/Fillmore laboratories on the U87 glioma cell line, as shown in Figure 15.
These cells were transfected with sense and antisense MMP-2 constructs as well as the
control vector. In this assay the cells were not fluorescently labeled, bu instead the cells
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were fixed, stained, and counted by manual methods. The results from this assay support
the results seen in the U251 assay. The U87 cells transfccted with sense MMP-2 were
significantly more invasive than the cells transfected with the antisense or control. In this
assay however, the invasion of U87 antisense cells was significantly higher than that of
the control cells (Fillmore, personal communication). The reason for this is unknown. It
leads to the thought that if the antiscnse MMP-2 is in fact blocking MMP-2 induction as
it was designed to do, what repercussions could occur. If MMP-2 is knocked out, what
else could be affected? It is also possible that with the addition of conA to activate proMMP-2, the opposite results may be seen. In addition, it would be useful to repeat this
assay using the fluorescent method to sec if the results are duplicated.

50
p <0.02
control vs sense

40

p < 0 .0 2
control vs antisense

c::::J control
llilliilllll3 sense
mm.tmm antisense

30

%1nva ion

p <0.05
sense vs antisense

20

10

0

Figure 15: U87 MMP2 stable transfcctants Invasion assay on U87 human glioma cells
transfcctcd with sense, antiscnse, and control construct conducted by the
Broaddus/Fillmore laboratories at MCV. Invasion assay was run for 48 hours and cells
were fixed, stained and counted to determine % invasion. T-tcsts were run to determine
statistical significance (Fillmore, personal communication).
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It is also possible that in activating MMP-2, by the tetravalent lectin concanavalin

A (conA), known to induce a marked activation of pro-MMP-2 (Gingras, 2000), a
difference in invasion between the control cells and the sense cells could be seen. In such
an experiment, I predict that a large increase in invasion by the cells transfected with
sense MMP-2 and a significantly less invasion would be seen from the antisense cells.
Conducting such an assay would be an important next step in the continuation of this
research.
Other future work using the glioma cell lines transfected with the control vector,
sense MMP-2 and antisense MMP-2 would include a study on the regulation ofMMP-2.
Inducers of MMP-2 expression are generally thought to act at the level of transcriptional
activation of the gene and promoter elements. Bian and Sun have shown MMP-2 to play
a role in the regulation of the p53 promoter (Bian and Sun, 1997). Since LNZ-308 is p53
null, T98 has a p53 point mutation, and U87 contains wild-type p53, it would be
interesting to compare the invasion of cell lines differing in p53 status. It has also been
shown that irradiation might promote invasion-related gene expression by activation of
wild-typep53 and a resulting increase of MMP-2 expression. Sublethal irradiation of rat
glioma cells results in the formation of a greater number of tumor satellites in the rat
brain in vivo connected with enhanced MMP-2 and reduced tissue inhibitor of
metalloproteinases-2 expression (Wild-Bode, 2001). The newly created MMP-2
expression system can serve a valuable tool in future studies involving the affects of
irradiation on p53, MMP-2 expression, and glioma invasion.
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The in vitro invasion assays, as well as zymograms and Western blots, need to be
repeated with and with out the addition of conA. In addition, the assays need to be
conducted on the transfected T98 cells and the transfected LNZ.308 cells to see if similar
data results from these different glioma cell lines. If a direct link between overexpression
of MMP-2 and glioma invasion were seen in the in vitro invasion assays, the next step
would be to conduct in vivo invasion assays using a rat glioma model for the human
brain. The transfected cell lines could be fluorescently labeled to examine cellular
invasion through the rat brain.
In conclusion, though these experiments do not conclusively demonstrate that
MMP-2 plays the major role in glioma invasion, they do support the previous correlative
studies and provide valuable tools for future work towards this goal.
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